1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
The Blood Cancer Discovery Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years ...
A committee of three scientists named by the CEBP Editor-in-Chief selects the Award winner each year based on the committee’s evaluation of the following criteria: originality; scientific, clinical, ...
1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
Search for other works by this author on: ...
Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...
Suzhou Genhouse Pharmaceutical Co., Ltd., Suzhou, China.
1Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York. 2Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University ...
1Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. *Corresponding Author: Cari M. Kitahara, Division of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback